Global Pharmaceuticals & Biotech Most Popular Stocks

HLB PANAGENE

Market Cap: ₩75.8b

Develops products in the field of molecular diagnostics in South Korea.

Jenburkt Pharmaceuticals

Market Cap: ₹4.8b

Researches and develops, manufactures, and markets pharmaceutical and healthcare products in India.

Kohjin Bio

Market Cap: JP¥8.0b

Manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics.

ViGenCell

Market Cap: ₩75.7b

Specializes in immune cell therapy.

Decibel Cannabis

Market Cap: CA$75.0m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

MTL Cannabis

Market Cap: CA$74.6m

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.

MAIA Biotechnology

Market Cap: US$53.4m

MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer.

INmune Bio

Market Cap: US$53.4m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

Nykode Therapeutics

Market Cap: NOK 532.6m

A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.

OncoTherapy Science

Market Cap: JP¥7.9b

Engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan.

Odonate

Market Cap: US$53.3m

A pharmaceutical company, develops therapeutics for the treatment of cancer.

BioXcel Therapeutics

Market Cap: US$53.0m

Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.

Noile-Immune Biotech

Market Cap: JP¥7.9b

Researches and develops CAR-T cells for cancer immunotherapies.

Optipharm.CO.LTD

Market Cap: ₩73.6b

Operates as a biomedical solution provider in South Korea.

NeoImmuneTech

Market Cap: ₩73.5b

A clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics.

Vitrafy Life Sciences

Market Cap: AU$79.8m

Engages in the research, development, and commercialization of cryopreservation solutions in Australia.

Pharos iBio

Market Cap: ₩73.3b

Develops treatments for rare and refractory diseases using AI based drug development platform in South Korea.

Acrivon Therapeutics

Market Cap: US$52.2m

A clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.

PolyPid

Market Cap: US$52.2m

A clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs.

Amplia Therapeutics

Market Cap: AU$79.5m

A clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia.

APTOCROM

Market Cap: ₩73.1b

Distributes pharmaceutical products in South Korea.

Tien Liang BioTech

Market Cap: NT$1.6b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

UBI Pharma

Market Cap: NT$1.7b

UBI Pharma Inc. develops, manufactures, and sells pharmaceutical products in Taiwan.

CHA Vaccine Research Institute

Market Cap: ₩72.5b

Cha Vaccine Research Institute Co., Ltd., a research-oriented biotechnology company, researches and develops a range of vaccine products targeting infectious and chronic diseases.

Medical Developments International

Market Cap: AU$78.9m

Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.

Linical

Market Cap: JP¥7.7b

Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.

Psomagen

Market Cap: ₩71.6b

Engages in the provision omics solutions and contract laboratory services.

Medicus Pharma

Market Cap: US$51.1m

A biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets.

Serina Therapeutics

Market Cap: US$50.9m

A biotechnology company, develops drugs to treat neurological diseases and pain.

Herantis Pharma Oyj

Market Cap: €43.3m

A clinical stage biotechnology company, engages in the development of disease-modifying cerebral dopamine neurotrophic factor (CDNF) based therapies for Parkinson’s disease (PD).

EI- Nile for Pharmaceuticals and Chemical Industries

Market Cap: ج.م2.4b

Develops, produces, and sells pharmaceutical products in Egypt.

Abnova (Taiwan)

Market Cap: NT$1.5b

Manufactures and sells various recombinant proteins and antibodies.

Albert David

Market Cap: ₹4.5b

Manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally.

Actinium Pharmaceuticals

Market Cap: US$50.2m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

Relief Therapeutics Holding

Market Cap: CHF 40.0m

A biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases.

Enimmune

Market Cap: NT$1.5b

Operates as a biopharmaceutical Research and development, and marketing company in Taiwan.